Jaime DeSantiago

Jaime DeSantiago

Auto-generated profile, based on publicly available information

Jaime DeSantiago

Division of Cardiology

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
ASArvind Sridhar
Arvind Sridhar
JDJaime DeSantiago
Jaime DeSantiago
HCHanna Chen
Hanna Chen
MPMahmud Arif Pavel
Mahmud Arif Pavel
OLOlivia Ly
Olivia Ly
DDDawood Darbar
Dawood Darbar
Obesity is linked to an increased risk of atrial fibrillation (AF) via increased oxidative stress. While NADPH oxidase 2 (NOX2), a major source of oxidative stress and reactive oxygen species (ROS) in the heart, predisposes to AF, the underlying mechanisms remain unclear. Here, we studied NOX2-mediated ROS production in obesity-mediated AF using Nox2 -knockout mice and mature human induced pluripotent stem cell–derived atrial cardiomyocytes (hiPSC-aCMs). Diet-induced obesity (DIO) mice and hiPSC-aCMs treated with palmitic acid (PA) were infused with a NOX blocker (apocynin) and a NOX2-specific inhibitor, respectively. We showed that NOX2 inhibition normalized atrial action potential duration and abrogated obesity-mediated ion channel remodeling with reduced AF burden. Unbiased transcriptomics analysis revealed that NOX2 mediates atrial remodeling in obesity-mediated AF in DIO mice, PA-treated hiPSC-aCMs, and human atrial tissue from obese individuals by upregulation of paired-like homeodomain transcription factor 2 (PITX2). Furthermore, hiPSC-aCMs treated with hydrogen peroxide, a NOX2 surrogate, displayed increased PITX2 expression, establishing a mechanistic link between increased NOX2-mediated ROS production and modulation of PITX2. Our findings offer insights into possible mechanisms through which obesity triggers AF and support NOX2 inhibition as a potential novel prophylactic or adjunctive therapy for patients with obesity-mediated AF.

26 March 2012 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
PDF file
JDJ. DeSantiago
J. DeSantiago
DBD.J. Bare
D.J. Bare
ISIurii Semenov
Iurii Semenov
RMR.D. Minshall
R.D. Minshall
DGD.L. Geenen
D.L. Geenen
KBKathrin Banach
Kathrin Banach